NCT05618613
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05618613
Title Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer (ELONA)
Acronym ELONA
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Context Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cancer Treatment Centers of America - Western Regional Medical Center Phoenix Arizona 85338 United States Details
Cancer Treatment Centers of America - Midwestern Regional Center Zion Illinois 60099 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field